CBI raided Vivimed Labs over SBI fraud complaint; Telangana HC grants interim stay

Enforcement RaidCourt Stay ObtainedRegulatory & Legal View source PDF Explain this filing

VIVIMEDLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.5%Reaction day

₹7.57

prior close

₹7.50

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.0%-6.5% vs market

On the reaction day the stock moved 6.5 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.5

10m

+2.9

15m

+1.6

30m

+0.3

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

-5.5+1.0-6.5

Next day

-10.2+0.5-10.6

-5.7-0.0-5.7

-2.9-1.5-1.4

-7.0-2.2-4.8

-3.7-1.2-2.5

+1.1-2.4+3.4

15d

-7.0-8.8+1.8

-8.9-8.3-0.6

-2.8-3.5+0.8

-11.5+6.4-17.9

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

CBI conducted search and seizure at Vivimed Labs on 20 Jan 2026 based on an SBI complaint that classified the company's account as 'fraud'. The company approached the Telangana High Court, arguing the fraud classification was already suspended in an earlier writ petition. On 06 Feb 2026, the court granted an interim stay, restraining CBI from taking any coercive action against the company and its directors. Next hearing is on 06 March 2026.

Likely market impact

Short-term relief from CBI action, but major legal overhang remains. SBI fraud classification still in dispute. Next hearing 06 March 2026.